These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 3729640)

  • 1. Prevention of amphotericin B-induced rigors by dantrolene.
    Gross MH; Fulkerson WJ; Moore JO
    Arch Intern Med; 1986 Aug; 146(8):1587-8. PubMed ID: 3729640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dantrolene for amphotericin B-induced rigors.
    da Camara CC; Lane TW
    Arch Intern Med; 1987 Dec; 147(12):2220. PubMed ID: 3689078
    [No Abstract]   [Full Text] [Related]  

  • 3. Dantrolene sodium for the treatment of aldesleukin-induced rigors in a melanoma patient.
    Azari LM; Sheehan VS; Sachdev JC; Jones TS
    Ann Pharmacother; 2012 May; 46(5):e11. PubMed ID: 22510667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beneficial effects of dantrolene in the treatment of neuroleptic malignant syndrome: a report of two cases.
    Goulon M; de Rohan-Chabot P; Elkharrat D; Gajdos P; Bismuth C; Conso F
    Neurology; 1983 Apr; 33(4):516-8. PubMed ID: 6682201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Rigidity abolished by intravenous dantrolene in a patient with Parkinson's disease under spinal anesthesia].
    Imoto Y; Fukuda Y; Yokoyama H; Miyake T
    Masui; 1992 Mar; 41(3):464-7. PubMed ID: 1560588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors related to amphotericin-B-induced rigors (shivering).
    Carney-Gersten P; Giuffre M; Levy D
    Oncol Nurs Forum; 1991; 18(4):745-50. PubMed ID: 2067963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neuroleptic malignant syndrome. Beneficial effects of dantrolene on hyperthermia and hypertonia (author's transl)].
    de Rohan Chabot P; Elkharrat D; Conso F; Bismuth C; Goulon M
    Nouv Presse Med; 1982 Mar; 11(14):1067-9. PubMed ID: 7079122
    [No Abstract]   [Full Text] [Related]  

  • 8. [Safety of long-term administration of conventional amphotericin B in oncology patients].
    Doubek M; Mayer J; Horký D
    Cas Lek Cesk; 2002 Mar; 141(5):156-9. PubMed ID: 11998223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liposomal amphotericin B for the treatment of severe fungal infection.
    Michaud D
    Dynamics; 2001; 12(1):17-21. PubMed ID: 11982230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of neuroleptic malignant syndrome with dantrolene.
    Goekoop JG; Carbaat PA
    Lancet; 1982 Jul; 2(8288):49-50. PubMed ID: 6123782
    [No Abstract]   [Full Text] [Related]  

  • 11. Video of dantrolene effectiveness on neuroleptic malignant syndrome associated muscular rigidity and tremor.
    Brvar M; Bunc M
    Crit Care; 2007; 11(3):415. PubMed ID: 17561987
    [No Abstract]   [Full Text] [Related]  

  • 12. Reversal of prolonged postoperative muscle rigidity by dantrolene: a case report.
    Dhandha SK
    Can J Anaesth; 1988 Jul; 35(4):425-7. PubMed ID: 3402020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroleptic malignant syndrome: response to dantrolene sodium.
    May DC; Morris SW; Stewart RM; Fenton BJ; Gaffney FA
    Ann Intern Med; 1983 Feb; 98(2):183-4. PubMed ID: 6824251
    [No Abstract]   [Full Text] [Related]  

  • 14. [Masseter muscle rigidity after suxamethonium during induction and postoperative abortive malignant hyperthermia in a patient with esophageal achalasia].
    Arakawa Y; Kuroiwa M; Anzai T; Kanai A; Okamoto H; Hoka S
    Masui; 2004 Mar; 53(3):287-90. PubMed ID: 15071881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute refractory hyperkalaemia and fatal cardiac arrest related to administration of liposomal amphotericin B.
    Groot OA; Trof RJ; Girbes AR; Swart NL; Beishuizen A
    Neth J Med; 2008 Nov; 66(10):433-7. PubMed ID: 19011270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Respiratory distress secondary to both amphotericin B deoxycholate and lipid complex formulation.
    Rolland WA; Guharoy R; Ramirez L; Blair D; Medicis J; Khan U
    Vet Hum Toxicol; 2000 Aug; 42(4):222-3. PubMed ID: 10928687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementation of clinical practice policy on the continuous intravenous administration of amphotericin B deoxycholate.
    Maharom P; Thamlikitkul V
    J Med Assoc Thai; 2006 Nov; 89 Suppl 5():S118-24. PubMed ID: 17718252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective study of amphotericin B formulations in immunocompromised patients in 4 European countries.
    Ullmann AJ; Sanz MA; Tramarin A; Barnes RA; Wu W; Gerlach BA; Krobot KJ; Gerth WC;
    Clin Infect Dis; 2006 Aug; 43(4):e29-38. PubMed ID: 16838223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treating neuroleptic malignant syndrome.
    Lazarus A
    Am J Psychiatry; 1984 Aug; 141(8):1014-5. PubMed ID: 6147102
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy of nefopam for the prevention and treatment of amphotericin B-induced shivering.
    Rosa G; Dell'Utri D; Conti G; Pelaia P; Cogliati A; Orsi P; Gasparetto A
    Arch Intern Med; 1997 Jul; 157(14):1589-92. PubMed ID: 9236561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.